VLife Sciences Technologies Pvt. Ltd. today announced that The Agency for Toxic Substances and Disease Registry (ATSDR), at Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA will use its flagship software product VLifeMDSTM 3.5, including its patented technology GQSAR and hybrid lead optimization approach VLife SCOPE (Structure Based Compound Optimization Prioritization and Evolution), for conducting cutting edge research in drug discovery and toxicology studies.

With this, VLife has added yet another top level research institute in the world to its list of users who have adopted this advanced technology platform. ‘We are very pleased to be associated with one of the finest center of disease control in the world. We are confident that with this advanced software the research community at ATSDR, Atlanta, USA will be able to expedite their research projects and further improve their R & D productivity’, said VLife’s CEO Mr. Supreet Deshpande.